Brian DeVivo

Bristol Myers Squibb, Associate Director of Cardiovascular Marketing @bmsnews #cardiology #hypertrophic cardiomyopathy #echo

[Brian DeVivo @devivo_brian]

Steelers 2025 season!

[J. Sawalla Guseh, M.D. @JSawallaGusehMD]

The first U.S. consensus on athletes with CV abnormalities came in 1985 (Bethesda). Since then, we’ve shifted from restriction to shared decision-making (SDM) & individualized risk assessment.

This new AHA/ACC statement reflects 40 years of progress—balancing performance, safety & autonomy.

Really honored to contribute alongside an amazing team.

📖 Read 👉🏾 https://t.co/7JV4R0Z1SY

[Brian DeVivo @devivo_brian]

@PGSportsNow He’s already made the hall of fame… although he’ll be remembered for how his career started, not how it ended!

[Brian DeVivo @devivo_brian]

@ThePoniExpress We waited anxiously to get what we consider our star wide receiver back to save our fluttering offense. Jamar Chase showed us what a star wide receiver looks and plays like last night. Why are we content with this disparity…

[Brian DeVivo @devivo_brian]

@ThePoniExpress Time for changes….

[Omar M. Abdelfattah, MD, FESC @AbdelfattahMD]

Power of #zeroLGE in #HCM holds a strong -ve predictive value at long-term follow up‼️Is it time to reconsider interval CMR rescan in low risk pts⁉️@mmartinezheart @HeartToProve @WiliamZoghbi @morristownheart @HMethodistCV

[Ahmad Masri @MasriAhmadMD]

Trajectory of patients with #HCM and NYHA class I in the SHaRe Registry. Important data.

https://t.co/RWNhLpIkwj

#CardioTwitter

[Brian DeVivo @devivo_brian]

@TheStandard412 @jack_sperry @KevinAdams26

[Srihari S. Naidu, MD @SrihariNaiduMD]

Some great news! The highlight of our book launch next week! We will be on @NBCNews at both 12:45 and 2:45 pm with both sets of hosts to discuss #SCA #HCM and how the book can raise awareness and help protect our society, esp as kids go back to school! Please tune in! @simplyzinhle @LindsayLuvDavis @AnkurKalraMD @docbhardwaj @djc795 @baileyannRN @Babar_Basir @DrMarthaGulati

[American Society of Echocardiography @ASE360]

We are pleased to share a new #HCM poster with you all, developed with support from @bmsnews!

Use this link to download the poster, "A Practical Approach to Echocardiographic Imaging in Patients with Hypertrophic Cardiomyopathy." https://t.co/UnQKH6uYw2

[HCMBeat @HCMBeat]

2024 Updated Guidelines for Management and Treatment of HCM https://t.co/hwFSwnnfq3 The new guidelines are out! Check out what is new. Thanks to @SteveOmmen @CarolynHoMD for inviting me to serve on the writing committee. It was a privilege.

[Brian DeVivo @devivo_brian]

@KDPomp @AdamSchefter This means the Steelers are all in on this season!

[Brian DeVivo @devivo_brian]

Supporting women in Cardiology https://t.co/J7sNsUzhf2

[Nosheen Reza, MD, MS @noshreza]

We're hiring at @PennCardiology! More positions posted — spread the word and reach out if you're interested in joining us!

🔗:https://t.co/MdNbq7hiqI

@tcappola1 @DanielKolansky @Dr_Mike_Fradley @MonSangh @Paul_J_Mather @jennlewey

[Nosheen Reza, MD, MS @noshreza]

Our @PennCardiology real-world experience with #mavacamten in patients with symptomatic #cvHCM — largest cohort with longest follow-up to date published — out now as simultaneous publication in @JACCJournals #JACCHF!

@tikuowens

[American College of Cardiology @ACCinTouch]

Check out ACC’s 🆕 resources including the HCM Pocket Guide, Essential EHR HCM Documentation & HCM Exercise Prescription, which support clinician & patient decision-making, disease pathology, access to care & latest science in managing #cvHCM. More: https://t.co/NgdllvWJPE

[Jordan Strom, MD, MSc, FACC, FASE @DocStrom]

Please participate in the @ASE360 trends survey - this is an important survey of the field to understand trends in #EchoFirst and needs for the ultrasound community. @RWASECEO @tabrahammd @SLittleMD

[American College of Cardiology @ACCinTouch]

What is the prevalence & penetrance of sarcomeric genes in clinical studies w/ patients & families w/ HCM as compared w/ population-based studies of asymptomatic individuals?

Read the journal scan for more: https://t.co/OvKKBZKSzI #cvGenetics

[Hypertrophic Cardiomyopathy Medical Society @hcmsociety]

Check out the HCMS 2023 Sessions Abstract Publication in @JCardFail that includes:
🫀Efficacy and safety of mavacamten treatment
🫀 AAV9-Mediated Gene Therapy
🫀 Characteristics of Patients in SEQUOIA-HCM
🫀 & much more!
https://t.co/XIfqnwHb0q

#HCM #Cardiology #CardioTwitter